Effect of Withania somnifera root powder on the levels of circulatory lipid peroxidation and liver marker enzymes in chronic hyperammonemia

E-Journal of Chemistry

Volumn 5, Issue 4, 2008, Pages 872-877

  Harikrishnan, B ^a   Subramanian, P ^a   Subash, S ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Hyperammonemia; Lipid peroxidation; Liver marker enzymes; Withania somnifera

Indexed keywords

EID: 57349161252     PISSN: None     EISSN: 09734945     Source Type: Journal    
DOI: 10.1155/2008/589394     Document Type: Article

References (33)

1. Murthy C R, Rama Rao K V, Bai G and Norenburg M D, J Neurosci Res., 2001, 66, 282.
2. Essa M M and Subramanian P, Fund Clin Pharmacol., 2006, 3, 299.
3. Kosenko E, Kaminsky A, Valencia M, Lee L, Hermenegildo C and Felipo V, Free Radic Res., 1997, 27, 637.
4. Lena P J and Subramanian P, Pharmazie, 2004, 59, 636.
5. Majeed K I, E Med J, 2005, 2, 12.
6. Owais M, Sharad K S, Shehbaz A and Saleemuddin M, Phytomedicine, 2005, 12, 229.
7. Dhuley J N, J.Ethnopharmacol., 2000, 70, 57
8. Gupta G L and Rana A C, Pharmacology Reviews., 2007, 1, 129.
9. Asthana R and Raina M K, Indian Drugs., 1989, 26, 199.
10. Grandhi A, Mujumdar A and Patwardhan B. J. Ethnopharmacol. 1994, 44, 131.
11. Gautam M, Diwanay S S, Gairola S, Shinde Y S, Jadhav S S and Patwardhan B K, Int. Immunopharmacol, 2004, 4, 841.
12. Rasool M and Varalakshmi P, Vascular Pharmacology, 2006, 44, 406.
13. Bhatnagar M, Jain C P and Sisodia S S, Cell Tissue Res., 2005, 5, 287.
14. Ganzera M, Choudhary M I and Khan I A, Fitoterapia, 2003, 74, 68.
15. Mishra L C, Singh B B and Dagenais S, Altern Med Rev., 2000, 5, 334.
16. Padmavathi B, Rath P C and Singh R P, Evid Based Complement Altemat Med., 2005, 2, 99.
17. Subash S, Subramanian P and Sivaperumal R, Cell Tissue Res., 2007, 7, 1043.
18. Khanam S and Devi K, Pharmacognosy Magazine, 2005, 1, 97.
19. Wolheim D F, Clin. Chern., 1984, 30, 906.
20. Varley H, Gowenlock A H and Bell M, Practical Clinical Biochemistry, 4th Ed., CBS Publishers: New Delhi, 1998.
21. Niehaus WG and Samuelsson B, Eur J Biochem., 1968, 17, 126.
22. Jiang Z Y, Hunt J V and Wolff S P, Anal Biochem., 1992, 202, 384.
23. Reitman S and Frankel A S, Am J Clin Pathol., 1957, 28, 56.
24. King E and Armstrong A R, Canad Med Assoc J, 1934, 31, 376.
25. Rasool M and Varalakshmi P, Vascular Pharmacology, 2006, 44, 406.
26. Nelson D L and Cox M M, Lehninger Principles of Biochemistry. Macmillan: London, 2000.
27. Kosenko E, Kaminsky Y, Stavroskaya I G and Felipo V, Brain Res., 2000, 880, 139.
28. Schliess F, Gorg B, Fischer R, Desjardins P, Bidmon H J, Herrmann A, Butterworth R F, Zilles K and Haussinger D, FASEB J, 2002, 16, 739.
29. Davis L and Kuttan G, Cancer Lett., 2000, 148, 9.
30. Ahmad M, Saleem S and Ahmad A S, Hum Exp Toxicol., 2005, 24, 137.
31. Devipriya S and Shyamaladevi C S, Ind J Pharmacol, 1999, 31, 422.
32. Jayaprakasam B, Zhang Y, Seeram N P and Nair M G, Life Sci., 2003, 74, 125.
33. Kaur P, Sharma M, Mathur S, Manisha T, Divekar H M., Kumar R, Srivastava K K, Chandra R. The Journal of Alternative and Complementary Medicine., 2003, 9, 897.